Guangzhou Wondfo Biotech Co.,Ltd

XSEC:300482 Stock Report

Market Cap: CN¥12.5b

Guangzhou Wondfo BiotechLtd Past Earnings Performance

Past criteria checks 4/6

Guangzhou Wondfo BiotechLtd has been growing earnings at an average annual rate of 9%, while the Medical Equipment industry saw earnings growing at 8.9% annually. Revenues have been growing at an average rate of 13.5% per year. Guangzhou Wondfo BiotechLtd's return on equity is 9.2%, and it has net margins of 18%.

Key information

9.0%

Earnings growth rate

9.0%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate13.5%
Return on equity9.2%
Net Margin18.0%
Last Earnings Update31 Mar 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown
Beta

How Guangzhou Wondfo BiotechLtd makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

XSEC:300482 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Mar 242,794502895389
31 Dec 232,765488880378
30 Sep 232,989357909369
30 Jun 233,136354880371
31 Mar 233,887497882395
01 Jan 235,6811,1971,175419
30 Sep 225,5501,2471,072424
30 Jun 225,5381,2571,153449
31 Mar 225,2901,3831,191427
31 Dec 213,361634930391
30 Sep 213,145695915339
30 Jun 213,060741870308
31 Mar 212,956692870303
31 Dec 202,811634826279
30 Sep 202,821663867265
30 Jun 202,711630812241
31 Mar 202,172413721182
31 Dec 192,072387667160
30 Sep 191,921375614163
30 Jun 191,817352576153
31 Mar 191,748325538149
31 Dec 181,650308504137
30 Sep 181,542280465116
30 Jun 181,498264408147
31 Mar 181,323231390117
31 Dec 171,14521135692
30 Sep 1792118131462
30 Jun 177471743220
31 Mar 176241542690
31 Dec 165471452350
30 Sep 165251582210
30 Jun 164861472040
31 Mar 164501311890
31 Dec 154291251730
30 Sep 153821061550
30 Jun 153801051480
31 Mar 15365961720
31 Dec 14365981450
31 Dec 1324859950

Quality Earnings: 300482 has high quality earnings.

Growing Profit Margin: 300482's current net profit margins (18%) are higher than last year (12.8%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 300482's earnings have grown by 9% per year over the past 5 years.

Accelerating Growth: 300482's earnings growth over the past year (1%) is below its 5-year average (9% per year).

Earnings vs Industry: 300482 earnings growth over the past year (1%) exceeded the Medical Equipment industry -1.4%.


Return on Equity

High ROE: 300482's Return on Equity (9.2%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.